Nelson, Van Denburg & Campbell Wealth Management Group, LLC Alkermes Plc. Transaction History
Nelson, Van Denburg & Campbell Wealth Management Group, LLC
- $2.42 Billion
- Q3 2024
A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 186 shares of ALKS stock, worth $5,397. This represents 0.0% of its overall portfolio holdings.
Number of Shares
186
Previous 186
-0.0%
Holding current value
$5,397
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ALKS
# of Institutions
363Shares Held
182MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$845 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$551 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$377 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$367 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$267 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.77B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...